{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:47:16Z","timestamp":1776408436063,"version":"3.51.2"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T00:00:00Z","timestamp":1567036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ebiom.2019.08.072","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T07:34:03Z","timestamp":1568964843000},"page":"257-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants"],"prefix":"10.1016","volume":"47","author":[{"given":"Nicole E.","family":"Naiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Slyker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Nduati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie M.","family":"Overbaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2019.08.072_bb0005","first-page":"288","article-title":"HIV vaccine research and discovery in the nonhuman primates model: a unified theory in acquisition prevention and control of SIV infection","volume":"8","author":"Lynch","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0010","doi-asserted-by":"crossref","first-page":"S307","DOI":"10.1016\/j.amepre.2015.09.004","article-title":"Prospects for a globally effective HIV-1 vaccine","volume":"49","author":"Excler","year":"2015","journal-title":"Am. J. Prev. Med"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1084\/jem.20161765","article-title":"Progress toward active or passive HIV-1 vaccination","volume":"214","author":"Escolano","year":"2017","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12514","article-title":"Complex immune correlates of protection in HIV-1 vaccine efficacy trials","volume":"275","author":"Tomaras","year":"2017","journal-title":"Immunol. Rev"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0025","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand","volume":"361","author":"Rerks-Ngarm","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0030","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","article-title":"Immune-correlates analysis of an HIV-1 vaccine efficacy trial","volume":"366","author":"Haynes","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0035","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/infdis\/jis367","article-title":"Magnitude and breadth of the neutralizing antibody response in the RV144 and Vax003 HIV-1 vaccine efficacy trials","volume":"206","author":"Montefiori","year":"2012","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0040","series-title":"Advances in Virus Research","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/bs.aivir.2017.10.001","article-title":"Chapter two - the role of immune responses in HIV mother-to-child transmission","volume":"vol. 100","author":"Milligan","year":"2018"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.chom.2015.03.002","article-title":"Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality","volume":"17","author":"Milligan","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0050","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1128\/JVI.02216-10","article-title":"The breadth and potency of passively acquired human immunodeficiency virus type 1-specific neutralizing antibodies do not correlate with the risk of infant infection","volume":"85","author":"Lynch","year":"2011","journal-title":"J. Virol"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0055","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/aid.1993.9.907","article-title":"Dynamics of maternal IgG antibody decay and HIV-specific antibody synthesis in infants born to seropositive mothers. The NYC perinatal HIV transmission study group","volume":"9","author":"Parekh","year":"1993","journal-title":"AIDS Res. Hum. Retrovir"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0060","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/cis662","article-title":"Has highly active antiretroviral therapy increased the time to seroreversion in HIV exposed but uninfected children?","volume":"55","author":"Gutierrez","year":"2012","journal-title":"Clin. Infect. Dis"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0065","first-page":"1039","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0070","first-page":"840","article-title":"Difficulties in assigning human immunodeficiency virus-1 infection and seroreversion status in a cohort of HIV-exposed in children using serologic criteria established by the Centers for Disease Control and Prevention","volume":"93","author":"Simpson","year":"1994","journal-title":"Pediatrics."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/INF.0b013e31818e03b4","article-title":"Failure of human immunodeficiency virus enzyme immunoassay to rule out infection among polymerase chain reaction-negative Vietnamese infants at 12 months of age","volume":"28","author":"Sohn","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0080","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/00006454-199505000-00009","article-title":"Seroreversion in human immunodeficiency virus-exposed but uninfected infants","volume":"14","author":"Chantry","year":"1995","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0085","doi-asserted-by":"crossref","first-page":"3374","DOI":"10.1016\/S0264-410X(03)00336-0","article-title":"Transfer of antibody via mother's milk","volume":"21","author":"Van de Perre","year":"2003","journal-title":"Vaccine."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002739","article-title":"HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads","volume":"8","author":"Mabuka","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0163-4453(99)90052-X","article-title":"Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988\u20131994","volume":"39","author":"Tranchat","year":"1999","journal-title":"J Infect"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/161.2.198","article-title":"Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers","volume":"161","author":"Ljunggren","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2249.1993.tb06497.x","article-title":"Antibody-dependent cellular cytotoxicity and neutralizing activity in sera of HIV-1-infected mothers and their children","volume":"93","author":"Broliden","year":"1993","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tim.2017.10.007","article-title":"Impact of HIV-1 envelope conformation on ADCC responses","volume":"26","author":"Richard","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/v11010069","article-title":"Structural basis for epitopes in the gp120 cluster a region that invokes potent effector cell activity","volume":"11","author":"Tolbert","year":"2019","journal-title":"Viruses."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/157016207782418560","article-title":"CD4-induced epitopes in the HIV envelope glycoprotein, gp120","volume":"5","author":"DeVico","year":"2007","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0125","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006866","article-title":"HIV: cell binding and entry","volume":"2","author":"Wilen","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0130","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1073\/pnas.1217609110","article-title":"Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding","volume":"110","author":"Guan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0135","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1128\/JVI.00171-11","article-title":"An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum","volume":"85","author":"Ferrari","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0140","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.ebiom.2015.09.001","article-title":"HIV-specific CD4-induced antibodies mediate broad and potent antibody-dependent cellular cytotoxicity activity and are commonly detected in plasma from HIV-infected humans","volume":"2","author":"Williams","year":"2015","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0145","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1128\/JVI.01023-12","article-title":"Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family","volume":"86","author":"Bonsignori","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0150","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01823-18","article-title":"Two families of Env antibodies efficiently engage fc-gamma receptors and eliminate HIV-1-infected cells","volume":"93","author":"Anand","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0155","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1128\/JVI.02779-15","article-title":"A highly conserved residue of the HIV-1 gp120 inner domain is important for antibody-dependent cellular cytotoxicity responses mediated by anti-cluster A antibodies","volume":"90","author":"Ding","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0160","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00358-18","article-title":"Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses","volume":"9","author":"Richard","year":"2018","journal-title":"MBio."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0165","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01901-18","article-title":"CD4- and time-dependent susceptibility of HIV-1-infected cells to antibody-dependent cellular cytotoxicity","volume":"93","author":"Lee","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0170","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1128\/JVI.01232-15","article-title":"Cocrystal structures of antibody N60-i3 and antibody JR4 in complex with gp120 define more cluster A epitopes involved in effective antibody-dependent effector function against HIV-1","volume":"89","author":"Gohain","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0175","doi-asserted-by":"crossref","first-page":"6127","DOI":"10.1128\/JVI.00347-16","article-title":"Comparison of antibody-dependent cell-mediated cytotoxicity and virus neutralization by HIV-1 Env-specific monoclonal antibodies","volume":"90","author":"von Bredow","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0180","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02452-16","article-title":"Influence of the envelope gp120 Phe 43 cavity on HIV-1 sensitivity to antibody-dependent cell-mediated cytotoxicity responses","volume":"91","author":"Prevost","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1742-4690-11-15","article-title":"HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2","volume":"11","author":"Pham","year":"2014","journal-title":"Retrovirology."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0190","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1128\/JVI.03230-13","article-title":"Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity","volume":"88","author":"Veillette","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0195","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.02194-14","article-title":"Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection","volume":"88","author":"Acharya","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0200","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.str.2017.09.009","article-title":"Targeting the late stage of HIV-1 entry for antibody-dependent cellular cytotoxicity: structural basis for Env epitopes in the C11 region","volume":"25","author":"Tolbert","year":"2017","journal-title":"Structure."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0205","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.str.2016.03.005","article-title":"Paring down HIV Env: design and crystal structure of a stabilized inner domain of HIV-1 gp120 displaying a major ADCC target of the A32 region","volume":"24","author":"Tolbert","year":"2016","journal-title":"Structure."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0210","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1128\/JVI.00156-14","article-title":"HIV-1 vaccine-induced C1 and V2 Env-specific antibodies synergize for increased antiviral activities","volume":"88","author":"Pollara","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0215","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.chom.2019.03.002","article-title":"An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity","volume":"25","author":"Alsahafi","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0220","doi-asserted-by":"crossref","first-page":"9019","DOI":"10.1073\/pnas.1301456110","article-title":"Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG","volume":"110","author":"Tomaras","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0225","doi-asserted-by":"crossref","first-page":"17477","DOI":"10.1073\/pnas.0707399104","article-title":"Antibodies to CD4-induced sites in HIV gp120 correlate with the control of SHIV challenge in macaques vaccinated with subunit immunogens","volume":"104","author":"DeVico","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0230","doi-asserted-by":"crossref","first-page":"E992","DOI":"10.1073\/pnas.1423669112","article-title":"Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection","volume":"112","author":"Fouts","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005042","article-title":"Human non-neutralizing HIV-1 envelope monoclonal antibodies limit the number of founder viruses during SHIV mucosal infection in rhesus macaques","volume":"11","author":"Santra","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0240","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jama.283.9.1167","article-title":"Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial","volume":"283","author":"Nduati","year":"2000","journal-title":"JAMA."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0245","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1128\/JCM.37.2.350-353.1999","article-title":"Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA","volume":"37","author":"Panteleeff","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0250","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/JCM.38.7.2688-2695.2000","article-title":"Evaluation of performance of the gen-probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya","volume":"38","author":"Emery","year":"2000","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0255","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1128\/JVI.75.24.12161-12168.2001","article-title":"Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1","volume":"75","author":"Hezareh","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0260","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.4049\/jimmunol.164.10.5313","article-title":"The IgG Fc contains distinct Fc receptor (FcR) binding sites: the leukocyte receptors Fc gamma RI and Fc gamma RIIa bind to a region in the Fc distinct from that recognized by neonatal FcR and protein A","volume":"164","author":"Wines","year":"2000","journal-title":"J. Immunol (Baltimore Md : 1950)"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007572","article-title":"Identification of HIV gp41-specific antibodies that mediate killing of infected cells","volume":"15","author":"Williams","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0270","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2005.09.018","article-title":"A simplified method for the rapid fluorometric assessment of antibody-dependent cell-mediated cytotoxicity","volume":"308","author":"Gomez-Roman","year":"2006","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0275","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/JVI.80.2.835-844.2006","article-title":"Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant","volume":"80","author":"Wu","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0280","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.4049\/jimmunol.157.5.2168","article-title":"HIV-1 gp120-specific antibody-dependent cell-mediated cytotoxicity correlates with rate of disease progression","volume":"157","author":"Baum","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0285","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00700-17","article-title":"HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV","volume":"91","author":"Madhavi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0290","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/QAD.0000000000000310","article-title":"Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design","volume":"28","author":"Madhavi","year":"2014","journal-title":"AIDS."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0295","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/QAD.0b013e328329f97d","article-title":"Heterogeneous neutralizing antibody and antibody-dependent cell cytotoxicity responses in HIV-1 elite controllers","volume":"23","author":"Lambotte","year":"2009","journal-title":"Aids."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2017.00005","article-title":"Indian long-term non-Progressors show broad ADCC responses with preferential recognition of V3 region of envelope and a region from tat protein","volume":"8","author":"Kulkarni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0305","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/QAI.0000000000001788","article-title":"Brief report: the anti-HIV-1 ADCC-mediating antibodies from Cervicovaginal secretions of HIV-infected women have an ability to mediate lysing of autologous CD4+ HIV-infected cells","volume":"79","author":"Dhande","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0310","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/aid.1990.6.341","article-title":"Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection","volume":"6","author":"Sawyer","year":"1990","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0315","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1086\/314988","article-title":"Antibody-dependent cellular cytotoxicity independently predicts survival in severely immunocompromised human immunodeficiency virus-infected patients","volume":"180","author":"Forthal","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1011087132180","article-title":"Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection","volume":"21","author":"Ahmad","year":"2001","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/QAI.0b013e31822c62b9","article-title":"Activation of NK cells by ADCC antibodies and HIV disease progression","volume":"58","author":"Chung","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0330","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2249.2012.04672.x","article-title":"Impaired natural killer cell-induced antibody-dependent cell-mediated cytotoxicity is associated with human immunodeficiency virus-1 disease progression","volume":"171","author":"Jia","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0335","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1089\/vim.2011.0025","article-title":"NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients","volume":"24","author":"Johansson","year":"2011","journal-title":"Viral Immunol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0340","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ebiom.2017.11.001","article-title":"Evaluation of different parameters of humoral and cellular immune responses in HIV Serodiscordant heterosexual couples: humoral response potentially implicated in modulating transmission rates","volume":"26","author":"Ruiz","year":"2017","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0345","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/imm.12016","article-title":"Specific antibody-dependent cellular cytotoxicity responses associated with slow progression of HIV infection","volume":"138","author":"Wren","year":"2013","journal-title":"Immunology."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0350","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ebiom.2016.09.004","article-title":"Co-receptor binding site antibodies enable CD4-mimetics to expose conserved anti-cluster a ADCC epitopes on HIV-1 envelope glycoproteins","volume":"12","author":"Richard","year":"2016","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0355","doi-asserted-by":"crossref","first-page":"42936","DOI":"10.1074\/jbc.M112.410217","article-title":"IgG Fab fragments forming bivalent complexes by a conformational mechanism that is reversible by osmolytes","volume":"287","author":"Nelson","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0360","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.immuni.2012.11.011","article-title":"Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2","volume":"38","author":"Liao","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0365","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00109-17","article-title":"Impaired downregulation of NKG2D ligands by Nef proteins from elite controllers sensitizes HIV-1-infected cells to antibody-dependent cellular cytotoxicity","volume":"91","author":"Alsahafi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0370","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00219-17","article-title":"BST-2 expression modulates small CD4-mimetic sensitization of HIV-1-infected cells to antibody-dependent cellular cytotoxicity","volume":"91","author":"Richard","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0375","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JVI.02868-14","article-title":"The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals","volume":"89","author":"Veillette","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0380","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02440-16","article-title":"Lack of ADCC breadth of human nonneutralizing anti-HIV-1 antibodies","volume":"91","author":"Bruel","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0385","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00484-18","article-title":"Incomplete downregulation of CD4 expression affects HIV-1 Env conformation and antibody-dependent cellular cytotoxicity responses","volume":"92","author":"Prevost","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0390","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1128\/JVI.02973-15","article-title":"Nef proteins from HIV-1 elite controllers are inefficient at preventing antibody-dependent cellular cytotoxicity","volume":"90","author":"Alsahafi","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0395","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1128\/JVI.00449-14","article-title":"HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells","volume":"88","author":"Alvarez","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0400","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1073\/pnas.1321507111","article-title":"Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity","volume":"111","author":"Arias","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0405","doi-asserted-by":"crossref","first-page":"10648","DOI":"10.1128\/JVI.01911-15","article-title":"Envelope glycoprotein internalization protects human and simian immunodeficiency virus-infected cells from antibody-dependent cell-mediated cytotoxicity","volume":"89","author":"von Bredow","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0410","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0415","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.chom.2008.03.001","article-title":"The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein","volume":"3","author":"Van Damme","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0420","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2015.12.004","article-title":"Small CD4 mimetics prevent HIV-1 uninfected bystander CD4 + T cell killing mediated by antibody-dependent cell-mediated cytotoxicity","volume":"3","author":"Richard","year":"2016","journal-title":"EBioMedicine."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0425","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.cell.2019.05.046","article-title":"Fc characteristics mediate selective placental transfer of IgG in HIV-infected women","volume":"178","author":"Martinez","year":"2019","journal-title":"Cell."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0430","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2012.07.006","article-title":"Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity","volume":"384","author":"Kramski","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0435","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1570162X113116660061","article-title":"HIV-specific antibody immunity mediated through NK cells and monocytes","volume":"11","author":"Kramski","year":"2013","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.ebiom.2019.08.072_bb0440","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jim.2018.08.012","article-title":"A flow cytometry based assay that simultaneously measures cytotoxicity and monocyte mediated antibody dependent effector activity","volume":"462","author":"Alrubayyi","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ebiom.2019.08.072_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087572","article-title":"Vaccine-induced IgG antibodies to V1V2 regions of multiple HIV-1 subtypes correlate with decreased risk of HIV-1 infection","volume":"9","author":"Zolla-Pazner","year":"2014","journal-title":"PLoS One"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419305948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396419305948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:59:49Z","timestamp":1762455589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396419305948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":89,"alternative-id":["S2352396419305948"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.072","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-dependent cellular cytotoxicity targeting CD4-inducible epitopes predicts mortality in HIV-infected infants","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2019.08.072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}